Hyun-Sil Park

Title: Hyun-Sil Park: Innovator in Cell Therapy for Immune Diseases

Introduction

Hyun-Sil Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cell therapy, particularly in the prevention and treatment of immune diseases. His innovative approach combines mesenchymal stem cells and immunoregulatory T-cells to enhance therapeutic outcomes.

Latest Patents

Hyun-Sil Park holds a patent for a cell therapy composition aimed at preventing or treating immune diseases. The patent, titled "Cell therapy composition for preventing or treating immune disease comprising mesenchymal stem cells and immunoregulatory T-cells as active ingredient," describes a method of infusing these cells into bone marrow transplant animals. This method effectively suppresses rejection to the host after the engraftment of transplanted bone marrow, thereby reducing graft-versus-host disease and other immune diseases. The results indicate that the combination of these two cell types yields a greater reduction in immune response compared to using mesenchymal stem cells alone.

Career Highlights

Hyun-Sil Park is affiliated with the Catholic University Industry Academic Cooperation Foundation, where he continues to advance research in cell therapy. His work has garnered attention for its potential to improve treatment options for patients suffering from immune diseases.

Collaborations

Hyun-Sil Park collaborates with notable colleagues, including Mi La Cho and Seok-Goo Cho. Their combined expertise contributes to the ongoing research and development of innovative therapies in the field.

Conclusion

Hyun-Sil Park's contributions to cell therapy represent a significant advancement in the treatment of immune diseases. His innovative patent and collaborative efforts highlight the potential for improved patient outcomes in this critical area of medicine.